The activation of ERK pathway can drive the apparent activation of super enhancer PD-L1L2-SE, the homeoregulatory element of PD-L1, and then up-regulate the expression of PD-L1 in tumor cells [57, 58]. This evidence concerns the gene CD274 and neoplasm.